Abstract
Introduction
Maintaining good glycemic control is the main therapeutic target for diabetes mellitus (DM) patients. Nevertheless, due to complex factors, the majority of patients worldwide persist poorly controlled. Hence the study was conducted to determine the association of anthropometric measurement and other factors with glycemic control among type 2 DM patients.
Methods
An institutional-based cross-sectional study was conducted among 366 type 2 DM patients from October-1 to November 30/2019. Data were collected by a pre-tested structured questionnaire and data abstraction format. The collected data were edited in Epi-data-4.4.1.0 and exported to SPSS-25 for analysis. The degree of association was assessed using logistic regression analysis and expressed in terms of p value and odds ratio with a 95%CI. p value < 0.05 was considered statistically significant.
Results
Of the total 366 participants, (66.1%) had poor glycemic control. Increased waist circumference (AOR 2.37, 95% CI 1.28–4.40 for overweight and AOR 3.31, 95% CI 1.28–8.58 for obesity), long duration of DM (AOR 2.12, 95% CI 1.14–3.95 for 5–10 years and AOR 5.67, 95% CI 1.76–11.30 for > 10 years), occupation (AOR 3.74, 95% CI 1.94–7.23 for government employee and AOR 4.90, 95% CI 2.19–10.94 for private employee), and family history of DM (AOR 1.93, 95% CI 1.08–3.43), were significantly associated with poor glycemic control.
Conclusion
Nearly two-thirds of study participants had poor glycemic control. Increased waist circumference, long duration of DM, occupational status, and family history of DM were independently associated with poor glycemic control. Therefore, type 2 DM patients with these identified factors should be strictly monitored to maintain good glycemic control.
Similar content being viewed by others
References
World Health Organization. Global Report on Diabetes. Geneva: World Health Organization; 2016. https://apps.who.int/iris/handle/10665/204871. Accessed 21 July 2019.
Cho NH, Shaw JE, Karuranga S, Huang Y, Rocha JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023.
IDF Diabetes Atlas, Eighth edition. 2017. http://fmdiabetes.org/wp-content/uploads/2018/03/IDF-2017.pdf. Accessed 27 July 2019.
American Diabetes Association. Standards of medical care in diabetes. 2017. https://professional.diabetes.org/files/media/dc_40_s1_final.pdf. Accessed 30 July 2019.
Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J. 2012;27(4):269–73.
Khattab M, Khader YS, Al-khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complicat. 2010;24(2):84–9. https://doi.org/10.1016/j.jdiacomp.2008.12.008.
Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drugs Healthc Patient Saf. 2014;6:155–65.
Bobby SK, Latha N. Impact of body mass index on glycemic control in type 2 diabetes mellitus. J Dental Med Sci. 2018;17(11):32–5. https://doi.org/10.9790/0853-1711073235.
Kayar Y, Ilhan A, Kayar NB, Unver N, Coban G, Hamdard J, et al. Relationship between poor glycemic control and risk factors, lifestyle, and complications. Int J Med Sci. 2017;28(4):1581–6.
Kibirige D, Lumu W, Jones AG, Smeeth L, Hattersley AT, Nyirenda MJ. Understanding the manifestation of diabetes in sub-Saharan Africa to inform therapeutic approaches and preventive strategies: a narrative review. Clin Diabetes Endocrinol. 2019;5(1):2. https://doi.org/10.1186/s40842-019-0077-8.
Tesfaye T, Shikur B, Shimels T, Firdu N. Prevalence and factors associated with diabetes mellitus and impaired fasting glucose level among members of federal police commission residing in Addis Ababa, Ethiopia. BMC Endocr Disord. 2016;16(1):68. https://doi.org/10.1186/s12902-016-0150-6.
Zekewos A, Loha E, Egeno T, Wubshet K, Merga Z. Prevalence of diabetes mellitus and associated factors in Southern Ethiopia: a community based study. Ethiop J Health Sci. 2018;28(4):451–60. https://doi.org/10.4314/ejhs.v28i4.11.
Demoz GT, Gebremariam A, Yifter H, Alebachew M, Niriayo YL, Gebreslassie G, et al. Predictors of poor glycemic control among patients with type 2 diabetes on follow-up care at a tertiary healthcare setting in Ethiopia. BMC Res Notes. 2019;12(1):207. https://doi.org/10.1186/s13104-019-4248-6.
Wabe NT, Angamo MT, Hussein S. Medication adherence in diabetes mellitus and self management practices among type-2 diabetics in Ethiopia. N Am J Med Sci. 2011;3(9):418–23. https://doi.org/10.4297/najms.2011.3418.
Patry-parisien J, Shields M, Bryan S. Comparison of waist circumference using the World Health Organization and National Institutes of Health protocols. Health Rep. 2012;23(3):53–60.
Barao K, Forones NM. Body mass index: different nutritional status according to WHO, OPAS, and Lipschitz classifications in gastrointestinal cancer patients. Arquivos de Gastroenterol. 2012;49(2):169–71.
World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee 1995. WHO Technical Report Series. 2017;854. https://apps.who.int/iris/bitstream/handle/10665/37003/WHO_TRS_854.pdf?sequence=1. Accessed 7 August 2019.
World Health Organization. Waist circumference and waist-hip ratio: report of a WHO expert consultation, Geneva. 2008. https://apps.who.int/iris/handle/10665/44583. Accessed 7 August 2019.
Ashwell M, Gibson S. Waist-to-height ratio as an indicator of ‘early health risk’: simpler and more predictive than using a ‘matrix’ based on BMI and waist circumference. BMJ Open. 2016;6(3):e010159.
Bayisa B, Bekele M. Glycemic control and associated factors among type II diabetic patients on chronic follow up at Southwest Ethiopia. J Med Health Sci. 2017;6(3):13–20.
Chetoui A, Kaoutar K, Elmoussaoui S, Boutahar K, El-Kardoudi A. Prevalence and determinants of poor glycaemic control: a cross-sectional study among Moroccan type 2 diabetes patients. Int Health. 2020. https://doi.org/10.1093/inthealth/ihz107.
Thuita A, Kiage-mokua BN, Onyango A, Makokha A. The relationship between patient characteristics and glycemic control (hba1c) in type 2 diabetes patients attending Thika level five hospital, Kenya. Afr J Food Agric Nutr Dev. 2019;19(4):15041–60.
Alzaheb RA, Altemani AH. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes Metab Syndr Obes Targets Ther. 2018;11:15–21.
Harrabi I, Al Harbi F, Al GS. Predictors of glycemic control among patients with type 2 diabetes in Najran Armed Forces Hospital: a pilot study. J Diabetes Mellit. 2014;4(02):141–7.
Haghighatpanah M, Sasan A, Nejad M, Haghighatpanah M, Thunga G. Factors that correlate with poor glycemic control in type 2 diabetes mellitus patients with complications. Osong Public Health Res Perspect. 2018;9(4):167–74. https://doi.org/10.24171/j.phrp.2018.9.4.05.
Huri HZ, Lim LP, Lim SK. Glycemic control and anti-diabetic drugs in type 2 diabetes mellitus patients with renal complications. Drug Design Dev Ther. 2015;9:4355–71. https://doi.org/10.2147/dddt.s85676.
Reisig V, Reitmeir P, Döring A, Rathmann W, Mielck A. Social inequalities and outcomes in type 2 diabetes in the German region of Augsburg. A cross-sectional survey. Int J Public Health. 2007;52(3):158–65.
Arai K, Hirao K, Matsuba I, Takai M, Matoba K, Takeda H, et al. The status of glycemic control by general practitioners and specialists for diabetes in Japan: a cross-sectional survey of 15,652 patients with diabetes mellitus. Diabetes Res Clin Pract. 2009;83(3):397–401.
Kakade AA, Mohanty IR, Rai S. Assessment of factors associated with poor glycemic control among patients with type II diabetes mellitus. Integr Obes Diabetes. 2018;4(3):1–6. https://doi.org/10.15761/IOD.1000209.
Unger R. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genet Clin Implic Diabetes. 1995;44(8):863–70. https://doi.org/10.2337/diab.44.8.863.
Greenberg AS, McDaniel ML. Identifying the links between obesity, insulin resistance, and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes. Eur J Clin Invest. 2002;32:24–34. https://doi.org/10.1046/j.1365-2362.32.s3.4.x.
Fasil A, Biadgo B, Abebe M. Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia. Diabetes Metab Syndr Obes Targets Ther. 2019;12:75–83.
Abebe SM, Berhane Y, Worku A, Alemu S, Mesfin N. Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study. Diabetes Metab Syndr Obes Targets Ther. 2015;8:65–71.
Fekadu G, Bula K, Bayisa G, Turi E, Tolossa T, Kasaye HK. Challenges and factors associated with poor glycemic control among type 2 diabetes mellitus patients at Nekemte Referral Hospital, Western Ethiopia. J Multidiscip Healthc. 2019;12:963–74.
Ahmad NS, Islahudin F, Paraidathathu T. Factors associated with good glycemic control among patients with type 2 diabetes mellitus. J Diabetes Investig. 2014;5(5):563–9.
Juarez DT, Sentell T, Tokumaru S, Goo R, Davis JW, Mau MM. Factors associated with poor glycemic control or wide glycemic variability among diabetes patients in Hawaii, 2006–2009. Prev Chronic Dis. 2012;9:120065. https://doi.org/10.5888/pcd9.120065.
Leibowitz G, Kaiser N, Cerasi E. β-cell failure in type 2 diabetes. J Diabetes Investig. 2011;2(2):82–91.
Acknowledgements
We would like to thank Department of Biomedical Sciences, Institute of Health, Jimma University, for logistic support for this study. We are also grateful to Debre Berhan Referral Hospital staff for their teamwork in the study. Finally, our deepest gratitude goes to the study participants for providing the required information for this study.
Funding
The authors received no financial support for this study and the study was funded by the authors.
Author information
Authors and Affiliations
Contributions
MMT: conceived the study, sample size calculation, and made major contributions to the study design and statistical analysis. BZ and MSE: participated in the conception, participated in the analysis and interpretation of the results, contributed to the writing of the manuscript. All authors contributed to the writing of the manuscript and approved the submitted version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declares that they have no competing interests.
Ethics approval
Ethical approval for this study was obtained from the Institutional Review Board (IRB) of the Institute of Health, Jimma University. The IRB had reviewed the study protocol and approved with ethical approval reference number IRB/498/2019. Permission and supportive letter were also obtained from Debre Berhan Referral hospital.
Informed consent
After informed about the purpose and the importance of their participation in the study, written informed consent was obtained from each study participant.
Statement on human research
All procedures followed were in accordance with the ethical standard of the Helsinki Declaration of 1964 and later versions. Furthermore, all findings of the study were utilized for the proper management of the patients.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Taderegew, M.M., Emeria, M.S. & Zegeye, B. Association of glycemic control and anthropometric measurement among type 2 diabetes mellitus: a cross-sectional study. Diabetol Int 12, 356–363 (2021). https://doi.org/10.1007/s13340-021-00490-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13340-021-00490-w